EUDA Health Holdings Limited Ordinary Shares (EUDA) Dividend History

Company News

• EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia

  Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its acquisition of CK Health Plus Sdn Bhd (“CK Health”) today. This strategic move marks an expansion of EUDA's presence in Malaysia and underscores its commitment to revolutionizing the healthcare landscape in the region.

  GlobeNewswire Inc.
• EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health

  SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus Sdn Bhd (“CK Health”), a direct seller of holistic wellness consumer products in Malaysia.

  GlobeNewswire Inc.
• EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

  Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating that the Company had failed to maintain a minimum market value of listed securities of $35 million over the previous 30 consecutive business days (the “MVLS Requirement”) as required by the Nasdaq Listing Rule 5550(b)(2).

  GlobeNewswire Inc.
• EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency

  Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on January 9, 2024 indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of $35 million over the previous 30 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).

  GlobeNewswire Inc.
• Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

  Gainers Cellectis S.A. (NASDAQ: CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting. Patriot Transportation Holding, Inc. (NASDAQ: PATI) climbed 104.8% to $15.73. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash. Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) gained 33% to $2.2780. Aldeyra Therapeutics entered into an exclusive option agreement with AbbVie Inc. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 30% to $6.82. Monopar Therapeutics Inc. (NASDAQ: MNPR) shares rose 29% to $0.5782. Monopar presented data showing tumor reduction benefit of camsirubicin from ongoing Phase 1b in patients with advanced soft tissue sarcoma at the 2023 Connective Tissue Oncology Society Annual Meeting. TG Therapeutics, Inc. (NASDAQ: TGTX) climbed 26.8% to $9.80 following third-quarter results. MSP Recovery, Inc. (NASDAQ: LIFW) gained 25% to $3.08. On Monday, the company announced that it is in compliance with all applicable Nasdaq listing standards. ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) climbed 20% to $0.0984. ZyVersa Therapeutics announced publication in molecular neurobiology reinforcing data demonstrating that inflammasome ASC inhibitor IC 100 attenuates the inflammatory response causing neuronal damage in multiple sclerosis model. EUDA Health Holdings Limited (NASDAQ: EUDA) rose 18.6% to $1.02. GDEV Inc. (NASDAQ: GDEV) shares gained 16.2% to $2.35 after falling 11% on Tuesday. Maison Solutions Inc. (NASDAQ: MSS) climbed 14.5% to $6.31. Generac Holdings Inc. (NYSE: GNRC) gained 13.7% to $95.60 following upbeat earnings. Mercury General Corporation (NYSE: MCY) gained 13.5% to $35.04 following quarterly results. Davis Commodities Limited (NASDAQ: DTCK) rose 13.4% to $4.1850. Newmark Group, Inc. (NASDAQ: NMRK) gained 13.4% to ...

  Benzinga

  Featured Companies: AIZ ALDX APO ASTE BALY BGFV CHEF CNDT DTCK EL EXTR FDP FTDR GDEV GNRC GOOS GRMN IRIX LUMN MCY MFH MNPR MSS MTCH MTZ NMRK PAYC PCTY PSTV SITE SLAB SMG SPWR SXC SYNA TGTX TNXP TRTX UNM YUMC ZVSA